MedPath
TGA Approval

INVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe (354080)

354080

INVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe

Janssen-Cilag Pty Ltd

February 10, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/bf4517786c1370ec11f3dc7bd71c7a68.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/0a53a1e5d47e6efc1a4afeeacb33c1e8.pdf

Active Ingredients

paliperidone palmitate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.